Anti-HIV Therapy in Senegal, West Africa


Principal Investigator:
Phyllis Kanki, Professor of Immunology and Infectious Diseases

Department of Immunology and Infectious Diseases

Dates of Research:
March 1, 2004 — November 15, 2007


This project aims to create an infrastructure and training model that will support the national ARV program in Senegal and provide important new data on treatment regimens applicable to the African setting. The specific goals are to: (1) Conduct clinical trials of the ARV therapy, (2) Establish and strengthen collaborations with clinicians involved with ARV therapy and develop methods of clinical management to enhance adherence to therapeutic regimes, and provide experience in clinical trials of ARV, and (3) Provide training for larger scale ARV programs, including several workshops and training fellowships that will allow investigators from other parts of Senegal and West Africa to train in ARV therapy programs.